SCHOLARLY PUBLICATION ✓ Open Access

Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy

Lais Osmani, Frederic Barton Askin, Edward Gabrielson, Qing Kay Li

📖 Seminars in Cancer Biology → 📅 2017-11-26 🔗 DOI: 10.1016/j.semcancer.2017.11.019

View Journal Profile → ⬇ Download PDF View Official Paper ↗

📄 Abstract

The abstract has not yet been added. Use the official source link for the complete publication record.

ℹ️ Publication Details

Journal: Seminars in Cancer Biology
Published: 2017-11-26
DOI: 10.1016/j.semcancer.2017.11.019
OpenAlex: W2769635882
Access: ✓ Open Access

📋 Cite This Paper

Lais Osmani, Frederic Barton Askin, Edward Gabrielson, Qing Kay Li (2017). Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2017.11.019

🔬 Related Research Papers

Seminars in Cancer Biology

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation

Veronica Huber, Chiara Camisaschi et al. 2017-03-06 · Read paper → Seminars in Cancer Biology

Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer

Peter T. Harrison, Simon Vyse, Paul H. Huang 2019-09-25 · Read paper → Seminars in Cancer Biology

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion

Dimitra Bourboulia, William George Stetler‐Stevenson 2010-05-13 · Read paper → Seminars in Cancer Biology

Sorting it out: Regulation of exosome loading

Carolina Villarroya‐Beltri, Francesc Baixauli et al. 2014-04-23 · Read paper → Seminars in Cancer Biology

Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression

Paolo Serafini, Ivan Borrello, Vincenzo Bronte 2005-09-16 · Read paper → Seminars in Cancer Biology

Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

Le Yu, Jessica C. Wei, Pengda Liu 2021-06-25 · Read paper → Seminars in Cancer Biology

Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance

Meran Keshawa Ediriweera, Kamani Hemamala Tennekoon, Sameera R. Samarakoon 2019-05-22 · Read paper → Seminars in Cancer Biology

Sustained proliferation in cancer: Mechanisms and novel therapeutic targets

Mark A. Feitelson, Alla L. Arzumanyan et al. 2015-04-17 · Read paper → Seminars in Cancer Biology

Pyruvate kinase type M2 and its role in tumor growth and spreading

Sybille Mazurek, C. Bruce Boschek et al. 2005-05-24 · Read paper →